Frontiers in Immunology
Cure8 research brief
Why This Matters
Metabolic interactions between epithelial and immune cells may help explain persistent inflammation and barrier problems in IBD and point to new therapeutic targets that could complement current immune-targeting drugs.
Who Should Pay Attention
Clinicians and researchers interested in IBD pathogenesis, metabolic-targeted therapies, and translational research; informed patients following research on novel treatment strategies.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is a review article from Frontiers in Immunology summarizing basic-science work linking epithelial mitochondrial metabolism to immune activation in the gut.
The authors describe how metabolic remodeling in epithelial and immune cells can act through signaling metabolites to influence barrier integrity and immune cell polarization toward pro‑inflammatory states.
The review frames metabolic pathways (glucose, lipid, amino acid metabolism and mitochondrial function) as potential targets for precision therapies, and it highlights mechanistic connections rather than reporting clinical trial results or approved treatments.
Because this is a scholarly review (structured content depth: abstract), it synthesizes existing studies to suggest research directions and therapeutic opportunities rather than presenting new clinical data.
Keep In Mind
This is a review article (abstract-level extraction). It synthesizes basic and translational studies but does not report new clinical trial outcomes. Translating metabolic-targeting strategies into safe, effective treatments will require further preclinical and clinical testing.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationFrontiers in Immunology
PublisherFrontiers Media SA
AuthorsHeng Li, Beibei Wang, Xianhong Shi +6 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedSep 28, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Probiotic-based sequential delivery system for gut-brain co-therapy against inflammatory bowel disease-associated anxiety/depression
The study presents a novel probiotic-based delivery system that targets both intestinal inflammation and anxiety/depression through the gut–brain axis, a potentially relevant concept for people with IBD who commonly...
Microbiome-driven alterations in tryptophan metabolism contribute to behavioral comorbidities in the Muc2 knockout mouse model of chronic colitis.
IBD is increasingly linked with anxiety, depression, and cognitive symptoms; this study suggests gut microbes may change tryptophan metabolism in colitis and contribute to those brain-related symptoms, which could point...
Treatable traits in inflammatory bowel disease: a conceptual framework for personalized care.
A treatable-traits approach could help tailor IBD care to each patient by targeting specific biological, comorbid, and psychosocial drivers of disease and quality-of-life impairment, potentially improving how we choose...